share_log

7 Analysts Have This To Say About Abbott Laboratories

7 Analysts Have This To Say About Abbott Laboratories

7位分析師對雅培公司的評論
Benzinga ·  07/02 23:02
Analysts' ratings for Abbott Laboratories (NYSE:ABT) over the last quarter vary from bullish to bearish, as provided by 7 analysts.
在過去的季度,7位分析師對雅培(NYSE:ABT)的評級從看好到看淡不一。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級概況,突出了過去30天內情緒的變化,並將其與之前的月份進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $125.0, along with a high estimate of $140.00 and a low estimate of $119.00. This current average has decreased by 2.21% from the previous average price target of $127.83.
此外,分析師們建立了12個月的價格目標,平均目標爲125.0美元,高估值爲140.00美元,低估值爲119.00美元。與之前的平均目標價相比,這個目標價平均數下降了2.21%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀:深入分析
A comprehensive examination of how financial experts perceive Abbott...
通過分析師的行爲,...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論